INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
KA
Koenig AmySVP, CLO, and Corp. Sec'y
DCDakota Gold Corp.
Option exercise
M$509K
100.0K sh
Jan 20, 2026Jan 23, 2026
Page 1405 of 1786
← PrevNext →
traded Jan 20, 2026
+3d
SEC Form 4

Evidence

28
RE
Reginelli EdwardCFO
BTGOBITGO HOLDINGS, INC.
Grant or award
A—
26.0K sh
Sep 17, 2025Jan 23, 2026
traded Sep 17, 2025
+128dSEC Form 4

Evidence

28
MJ
Mettler JodyChief Operating Officer
BTGOBITGO HOLDINGS, INC.
Option exercise
M—
10.0K sh
Jul 21, 2025Jan 23, 2026
traded Jul 21, 2025
+186dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
4,188 sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
910.5K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
723.6K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Tax withholding
F$587K
6,179 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
910.5K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Open-market sale
SELL$879K
73.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
723.6K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
723.6K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
910.5K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
723.6K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

27
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
910.5K sh
Sep 23, 2025Jan 23, 2026
traded Sep 23, 2025
+122dSEC Form 4

Evidence

26
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Grant or award
A$5.21M
67.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

26
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Open-market sale · 10b5-1 plan
SELL$599K
12.8K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

26
SA
Schreiber Daniel A.Director, Chief Executive Officer
LMNDLemonade, Inc.
Open-market sale · 10b5-1 plan
SELL$12.00M
126.6K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

26
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.96M
66.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

26
OD
Owens DarrellSee remarks
SYFSynchrony Financial
Grant or award
A$1.17M
15.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

26
SB
Schaller BartSee remarks
SYFSynchrony Financial
Tax withholding
F$1.82M
23.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

24
PS
Parasuraman SunitaDirector
BTGOBITGO HOLDINGS, INC.
Grant or award
A—
36.0K sh
Sep 6, 2025Jan 23, 2026
traded Sep 6, 2025
+139dSEC Form 4

Evidence

24
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M$93K
1,500 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

24
RE
Reginelli EdwardCFO
BTGOBITGO HOLDINGS, INC.
Option exercise
M—
48.0K sh
Sep 25, 2025Jan 23, 2026
traded Sep 25, 2025
+120dSEC Form 4

Evidence

24
RE
Reginelli EdwardCFO
BTGOBITGO HOLDINGS, INC.
Option exercise
M—
125.0K sh
Sep 25, 2025Jan 23, 2026
traded Sep 25, 2025
+120dSEC Form 4

Evidence

24
HT
Henderson Michael ThomasDirector
SYRESpyre Therapeutics, Inc.
Other acquisition or disposition
J—
63.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

23
GC
Gentleman CourtneySee remarks
SYFSynchrony Financial
Tax withholding
F$483K
6,267 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

22
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Tax withholding
F$2.26M
29.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

22
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$2.59M
65.8K sh
Jan 20, 2026Jan 23, 2026
traded Jan 20, 2026
+3dSEC Form 4

Evidence

22
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Tax withholding
F$2.30M
127.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
TJ
Thompson Amanda JChief People Officer
GAPGAP INC
Option exercise
M—
20.2K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

21
HK
Huffman Patrick KipSVP, Chief Accounting Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
950 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

21
FJ
Fogarty JaneEVP, Legal
CNXCConcentrix Corp
Grant or award
A—
13.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
MM
Moore MichaelPresident
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
8,554 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
3,334 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
HV
Hintelmann Robert Victor Jr.Chief Credit Officer
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
2,850 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

21
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,329 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
49.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
11.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
13.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

21
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
28.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence